Gentian Diagnostics ASA (FRA:6FK)

Germany flag Germany · Delayed Price · Currency is EUR
4.960
-0.030 (-0.60%)
At close: Jan 30, 2026
31.91%
Market Cap78.40M +46.7%
Revenue (ttm)14.72M +17.4%
Net Income3.65M +1,826.9%
EPS0.23 +1,810.5%
Shares Outn/a
PE Ratio21.48
Forward PE55.91
Dividend0.03 (0.70%)
Ex-Dividend DateMay 7, 2025
Volumen/a
Average Volume1
Open4.960
Previous Close4.990
Day's Range4.960 - 4.960
52-Week Range3.290 - 5.420
Betan/a
RSI56.56
Earnings DateFeb 11, 2026

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2001
Employees 63
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6FK
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements